BSTC Announces Positive Topline Results from Phase1

BSTC: BioSpecifics Technologies Corp.
2018-10-31 16:30:00
BioSpecifics Technologies Corp. Announces Positive Topline Results from Phase 1 Study of CCH for the Treatment of Uterine Fibroids